267 related articles for article (PubMed ID: 16570272)
21. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.
Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H
J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879
[TBL] [Abstract][Full Text] [Related]
22. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
Brognard J; Clark AS; Ni Y; Dennis PA
Cancer Res; 2001 May; 61(10):3986-97. PubMed ID: 11358816
[TBL] [Abstract][Full Text] [Related]
23. The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
Wu ZL; O'Kane TM; Connors TJ; Marino MJ; Schaffhauser H
Brain Res; 2008 Aug; 1227():42-51. PubMed ID: 18621031
[TBL] [Abstract][Full Text] [Related]
24. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP
Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
Galaria II; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
[TBL] [Abstract][Full Text] [Related]
26. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis.
Marushige K; Marushige Y
Anticancer Res; 1999; 19(5B):3865-71. PubMed ID: 10628325
[TBL] [Abstract][Full Text] [Related]
27. The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.
Tenzer A; Zingg D; Rocha S; Hemmings B; Fabbro D; Glanzmann C; Schubiger PA; Bodis S; Pruschy M
Cancer Res; 2001 Nov; 61(22):8203-10. PubMed ID: 11719451
[TBL] [Abstract][Full Text] [Related]
28. Expression of human TFF3 in relation to growth of HT-29 cell subpopulations: involvement of PI3-K but not STAT6.
Durual S; Blanchard C; Estienne M; Jacquier MF; Cuber JC; Perrot V; Laboisse C; Cuber JC
Differentiation; 2005 Feb; 73(1):36-44. PubMed ID: 15733066
[TBL] [Abstract][Full Text] [Related]
29. Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059.
Pathania AS; Joshi A; Kumar S; Guru SK; Bhushan S; Sharma PR; Bhat WW; Saxena AK; Singh J; Shah BA; Andotra SS; Taneja SC; Malik FA; Kumar A
Apoptosis; 2013 Dec; 18(12):1561-73. PubMed ID: 23948751
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
31. Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.
Du L; Smolewski P; Bedner E; Traganos F; Darzynkiewicz Z
Int J Oncol; 2001 Oct; 19(4):811-9. PubMed ID: 11562760
[TBL] [Abstract][Full Text] [Related]
32. Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Meiler J; Guyot M; Hoffarth S; Wesarg E; Höhn Y; Breitenbuecher F; Schuler M
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1385-94. PubMed ID: 22488173
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
34. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
35. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of gonadotropin alpha-subunit gene by phosphatidylinositol 3-kinase inhibitors in clonal gonadotroph cells.
Kanasaki H; Mutiara S; Oride A; Miyazaki K
Neuro Endocrinol Lett; 2008 Aug; 29(4):529-35. PubMed ID: 18766138
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Gene33 expression by insulin requires MEK-ERK activation.
Keeton AB; Xu J; Franklin JL; Messina JL
Biochim Biophys Acta; 2004 Sep; 1679(3):248-55. PubMed ID: 15358516
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
Badinloo M; Esmaeili-Mahani S
Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]